Emily
Editor, Senior Moderator
https://www.i24news.tv/en/news/coro...-drug-for-severe-covid-shows-94-survival-rate
Israeli drug for severe Covid shows 94% survival rate
i24NEWS
November 24, 2021, 06:21 PMlatest revision November 25, 2021, 10:58 AM
Bonus BioGroup seeking emergency use authorization after successful Phase II clinical trial
An Israeli-made drug for the treatment of severe cases of Covid-19 displayed impressive results in Phase II clinical trials with a survival rate of 94 percent for the participants.
According to data released this week by biotechnology company Bonus BioGroup, 47 out of 50 patients hospitalized in severe condition who received up to three doses of the company’s cell therapy MesenCure survived...
______________________________________________________________________________
I think this one is still in trial, too.
https://www.timesofisrael.com/feeli...rug-for-critically-ill-starts-phase-3-trials/
Feeling better ‘in 2 hours’: COVID drug for critically ill starts Phase 3 trials
Experimental Israeli-made drug Allocetra, developed at Jerusalem’s Hadassah hospital, being used to treat so-called cytokine storm, whereby immune system attacks body’s own organs
By TOI staff 9 February 2021, 11:11 pm
...
One recovered patient, 49-year-old building inspector Yair Tayeb, spoke on his release from the hospital three days after getting the drug.
“I couldn’t breathe, I could barely speak. [I was in] very very serious condition,” Tayeb said. “I went through an experience you can’t put into words.”
Within two hours of receiving the drug, he said, he felt a change. “They gave me the drug. Suddenly after two hours I started feeling something strange in my body. I stopped coughing, my breathing started to come back, I was feeling better. I stopped sweating. I couldn’t believe it. I was afraid to tell people I was okay, I was so excited.”../
Israeli drug for severe Covid shows 94% survival rate
i24NEWS
November 24, 2021, 06:21 PMlatest revision November 25, 2021, 10:58 AM
Bonus BioGroup seeking emergency use authorization after successful Phase II clinical trial
An Israeli-made drug for the treatment of severe cases of Covid-19 displayed impressive results in Phase II clinical trials with a survival rate of 94 percent for the participants.
According to data released this week by biotechnology company Bonus BioGroup, 47 out of 50 patients hospitalized in severe condition who received up to three doses of the company’s cell therapy MesenCure survived...
______________________________________________________________________________
I think this one is still in trial, too.
https://www.timesofisrael.com/feeli...rug-for-critically-ill-starts-phase-3-trials/
Feeling better ‘in 2 hours’: COVID drug for critically ill starts Phase 3 trials
Experimental Israeli-made drug Allocetra, developed at Jerusalem’s Hadassah hospital, being used to treat so-called cytokine storm, whereby immune system attacks body’s own organs
By TOI staff 9 February 2021, 11:11 pm
...
One recovered patient, 49-year-old building inspector Yair Tayeb, spoke on his release from the hospital three days after getting the drug.
“I couldn’t breathe, I could barely speak. [I was in] very very serious condition,” Tayeb said. “I went through an experience you can’t put into words.”
Within two hours of receiving the drug, he said, he felt a change. “They gave me the drug. Suddenly after two hours I started feeling something strange in my body. I stopped coughing, my breathing started to come back, I was feeling better. I stopped sweating. I couldn’t believe it. I was afraid to tell people I was okay, I was so excited.”../
